FDAFDA · Food and drugs·Recall number D-0354-2023
Gabapentin Tablets, USP 600 mg, 500 tablets per bottle, RX Only, Manufactured by ScieGen Pharmaceuticals Inc., Hauppauge, NY 11788, NDC: 50228-177-05.
Published March 8, 2023 · Recall initiated: February 17, 2023
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Presence of Foreign Tablets/Capsules: Pharmacist reported presence of some Gabapentin tablets 800 mg comingled in Gabapentin 600 mg 500 count bottles.
What to do
Voluntary: Firm initiated · Letter
Recall details
- Brand
- GABAPENTIN
- Manufacturer
- Sciegen Pharmaceuticals Inc
- Distributor
- Nationwide in the USA and Puerto Rico
- UPC
- 0350228180108
- Lot
- Lot # G177092, Exp. 11/24
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.